CUA Educational Content

[CUA Podcast] Milestones in Advanced Bladder Cancer

EDITORIAL COMMITTEE: Aly-Khan Lalani & Nimira Alimohamed

In this podcast, Dr. Nimira Alimohamed and Dr. Aly-Khan Lalani review the recent data from trials in advanced bladder cancer including the 5-year survival update of the KEYNOTE-045 trial presented at ASCO in June 2021. The hosts will discuss the impact of immunotherapy and other novel therapeutic strategies on the management of patients with advanced bladder cancer in Canada.

Start Quiz for Credits

ACCREDITATION

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Urological Association. You may claim a maximum of 2 hours of credit.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy